Association of Chronic Kidney Disease and Peripheral Artery Disease with Inappropriate Left Ventricular Mass

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Su, Ho Ming ^a,b,c   Lin, Tsung Hsien ^a,c   Hsu, Po Chao ^a   Lee, Chee Siong ^a,c   Lee, Wen Hsien ^a   Chen, Szu Chia ^a,b,c   Voon, Wen Chol ^a,c   Lai, Wen Ter ^a,c   Sheu, Sheng Hsiung ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INAPPOPRIATE LEFT VENTRICLE MASS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PREVALENCE; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANKLE BRACHIAL INDEX; FEMALE; GLOMERULAR FILTRATION RATE; HEART VENTRICLES; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; ORGAN SIZE; PERIPHERAL ARTERIAL DISEASE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84868318338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048422     Document Type: Article

References (42)

1. Nardi E, Palermo A, Mule G, Cusimano P, Cottone S, et al. (2009) Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 27: 633-641.
2. de Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, et al. (1998) Interaction between body size and cardiac workload: Influence on left ventricular mass during body growth and adulthood. Hypertension 31: 1077-1082.
3. Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, et al. (2007) Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertens 25: 1073-1078.
4. de Simone G, Palmieri V, Koren MJ, Mensah GA, Roman MJ, et al. (2001) Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens 19: 119-125.
5. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP, (2002) Prognosis of inappropriate left ventricular mass in hypertension: The mavi study. Hypertension 40: 470-476.
6. Cioffi G, Tarantini L, Frizzi R, Stefenelli C, Russo TE, et al. (2011) Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. J Hypertens 29: 565-573.
7. Chen SC, Chang JM, Liu WC, Chen YY, Chen LI, et al. (2012) The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res 35: 832-838.
8. de Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, et al. (2005) Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int Suppl 93: S44-47.
9. Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H, (2002) The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: Requirements for diagnostics. Am J Kidney Dis 40: 472-479.
10. Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, et al. (2008) The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg 48: 1197-1203.
11. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, et al. (1997) Calcification of medial elastic fibers and aortic elasticity. Hypertension 29: 999-1006.
12. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57: 450-458.
13. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, et al. (2003) Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects. Atherosclerosis166: 303-309.
14. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, et al. (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25: 359-364.
15. Yokoyama H, Shoji T, Kimoto E, Shinohara K, Tanaka S, et al. (2003) Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease. J Atheroscler Thromb 10: 253-258.
16. Vickery S, Stevens PE, Dalton RN, van Lente F, Lamb EJ, (2006) Does the id-ms traceable mdrd equation work and is it suitable for use with compensated jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 21: 2439-2445.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130: 461-470.
18. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK, (1996) Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 27: 668-672.
19. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, et al. (1991) Edinburgh artery study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20: 384-392.
20. Newman AB, Tyrrell KS, Kuller LH, (1997) Mortality over four years in shep participants with a low ankle-arm index. J Am Geriatr Soc 45: 1472-1478.
21. Orchard TJ, Strandness DE Jr, (1993) Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the american heart association and the american diabetes association 18-20 september 1992, new orleans, louisiana. Diabetes Care 16: 1199-1209.
22. Levin A, Djurdjev O, Barrett B, Burgess E, Carlisle E, et al. (2001) Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kidney Dis 38: 1398-1407.
23. Shinohara K, Shoji T, Tsujimoto Y, Kimoto E, Tahara H, et al. (2004) Arterial stiffness in predialysis patients with uremia. Kidney Int 65: 936-943.
24. O'Hare A, Johansen K, (2001) Lower-extremity peripheral arterial disease among patients with end-stage renal disease. J Am Soc Nephrol 12: 2838-2847.
25. O'Hare AM, Hsu CY, Bacchetti P, Johansen KL, (2002) Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 13: 497-503.
26. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA, (1993) Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 7: 523-527.
27. Guerrero A, Montes R, Munoz-Terol J, Gil-Peralta A, Toro J, et al. (2006) Peripheral arterial disease in patients with stages iv and v chronic renal failure. Nephrol Dial Transplant 21: 3525-3531.
28. Ono K, Tsuchida A, Kawai H, Matsuo H, Wakamatsu R, et al. (2003) Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 14: 1591-1598.
29. Ritz E, (2006) Heart and kidney: Fatal twins? Am J Med 119: S31-39.
30. Levin A, Singer J, Thompson CR, Ross H, Lewis M, (1996) Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27: 347-354.
31. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, et al. (1999) Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134.
32. Scandinavian Simvastatin Survival Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastatin survival study (4s). Lancet 344: 1383-1389.
33. Hunter JJ, Chien KR, (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341: 1276-1283.
34. Devereux RB, Reichek N, (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618.
35. Fu W, Ye C, Mei C, Rong S, Wang W, (2006) Reverse correlation between ankle-brachial index and left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrology (Carlton) 11: 9-14.
36. Ix JH, Katz R, Peralta CA, de Boer IH, Allison MA, et al. (2010) A high ankle brachial index is associated with greater left ventricular mass mesa (multi-ethnic study of atherosclerosis). J Am Coll Cardiol 55: 342-349.
37. Su HM, Lin TH, Hsu PC, Chu CY, Lee WH, et al. (2012) Abnormally low and high ankle-brachial indices are independently associated with increased left ventricular mass index in chronic kidney disease. PLoS One (In press).
38. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, et al. (2000) Impact of arterial stiffening on left ventricular structure. Hypertension 36: 489-494.
39. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB, (1995) Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 25: 83-90.
40. Levey AS, Coresh J, Bolton K, Culleton B, Harvey KS, et al. (2002) Initiative KDOQ. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
41. Eckardt KU, Berns JS, Rocco MV, Kasiske BL, (2009) Definition and classification of ckd: The debate should be about patient prognosis-a position statement from kdoqi and kdigo. Am J Kidney Dis 53: 915-920.
42. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, et al. (2011) The definition, classification, and prognosis of chronic kidney disease: A kdigo controversies conference report. Kidney Int 80: 17-28.